Press Release

Next-Generation Sequencing Market Cross US$ 31,411.3 Mn by 2026

Next-Generation Sequencing Market Key Players Analysis, Industry Share, Size by 2026

The Global Next-Generation Sequencing Market is forecast to exhibit a remarkable CAGR as the next-generation sequencing platform allows effective sequencing of millions of DNA molecules. Fortune Business Insights in a new report, titled “Next-Generation Sequencing: Global Market Analysis, Insights and Forecast, 2019-2026” offers a detailed analysis of the competitive landscape and market dynamics.

Get Sample PDF [email protected]

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/next-generation-sequencing-ngs-market-101000

As per the report, the global market is expected to rise at a ferocious CAGR of 22.2% between 2018 and 2026. In 2018, the market was worth US$ 6,335.2 Mn and the market will be a howling success as it is projected to reach US$ 31,411.3 Mn by 2026.  The demand for next-generation sequencing methodologies is increasing rapidly across several applications such as diagnostics, clinical research among others.

“Some of the Main Key Players Covered in the Report” 

  • IlluminaNext-Generation Sequencing Market
  • Thermo Fisher Scientific
  • Roche
  • Agilent Technologies
  • QIAGEN
  • BGI
  • PerkinElmer Inc.
  • Eurofins Scientific
  • Macrogen, Inc.
  • PierianDx

Browse Complete Report Details @

https://www.fortunebusinessinsights.com/industry-reports/next-generation-sequencing-ngs-market-101000

“Demand for Next-Generation Sequencing Services to Rising at a High Pace”

Next-generation sequencing products encompass instruments, consumables, and software. According to the findings from the report, the next-generation sequencing product segment is anticipated to lead the market over the forecast period. This is ascribable to some primary factors such as new product launches, high usage of consumables, and easy availability. Apart from next-generation sequencing products, next-generation sequencing services are expected to grow at a higher CAGR during the forecast period.

The need for novel platforms regarding advancements in bioinformatics and fast DNA data interpretation are paving the way for start-ups, especially for next-generation sequencing services. With the introduction of next-generation sequencing, the cost of sequencing has reduced over the years.

“Key segmentation”

By Type

  • Products
  • Instruments & Software
  • Consumables
  • Services

By Application

  • Diagnostics
  • Research

By End User

  • Research Institutes
  • Healthcare Facilities & Diagnostic Centers
  • Pharmaceutical & Biotechnological Companies
  • Contract Research Organization (CROs)

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Order Full Report @ https://www.fortunebusinessinsights.com/checkout-page/101000

Saphetor SA and Swift Biosciences Inc.’s Partnership Aims to Target Next-Generation Sequencing Panels

Strategic partnerships and new product launches are increasingly adopted by companies as these help them to maintain their position in the market. Some of the industry developments are mentioned below:

  • PierianDx joined hands with Illumina, Inc. in January 2019, to fulfil the needs of customers by offering informatics services for Illumina’s oncology products. This will further support cancer diagnostics and research.
  • Saphetor SA partners with Swift Biosciences Inc. in June 2019. The partnership aims at standardizing and accelerating data interpretation solutions for next-generation sequencing panels.
  • Agilent Technologies, Inc. announces the launch of a next-generation sequencing solution called Agilent OnePGT in June 2018. This solution aims at offering Preimplantation Genetic Testing (PGT).

Companies such as Illumina, Inc., Thermo Fisher Scientific Inc., and F. Hoffmann-La Roche Ltd are likely to lead in the global next-generation sequencing market. This is mainly on account of their strong geographical presence and diversified product portfolio. Moreover, Illumina was leading in the global market owing to its rising product sales. New product launches also helped the company to strengthen its market position.

More Trending Topics from Fortune Business Insights:

X-ray Flat Panel Detectors Market to Value US$ 2805.2 Mn by 2026, Introduction of Retrofit X-ray System to Push Growth Rate, says Fortune Business Insights

Thrombin Market to be valued at US$ 738.7 Mn by 2025, Contributions from Baxter and Pfizer to drive Growth, says Fortune Business Insights

Retinal Disease Therapeutics Market to Reach US$ 21,318.0 Mn by 2026, Advancements in Retinal Disease Diagnosis Devices to Boost the Market, says Fortune Business Insights

Tags

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close